Detalhe da pesquisa
1.
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
J Natl Compr Canc Netw
; 20(2): 160-166, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130494
2.
Optimizing First-Line Therapy for Follicular Lymphoma: Is It Time for Chemotherapy-Free Approaches?
J Natl Compr Canc Netw
; 17(11.5): 1414-1416, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766017
3.
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
Biol Blood Marrow Transplant
; 24(4): 700-707, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289757
4.
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.
Am J Hematol
; 93(4): 486-493, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29266344
5.
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Nature
; 490(7418): 116-20, 2012 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22885699
6.
RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
Br J Haematol
; 176(5): 759-769, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27992063
7.
Subtype-specific therapy for DLBCL: are we there yet?
Blood
; 126(16): 1869-70, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26472733
8.
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.
Blood
; 125(2): 236-41, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395425
9.
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.
J Natl Compr Canc Netw
; 15(3): 293-311, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275031
10.
Oncogenically active MYD88 mutations in human lymphoma.
Nature
; 470(7332): 115-9, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21179087
11.
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
Br J Haematol
; 172(2): 208-18, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26492567
12.
Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers.
Oncologist
; 26(7): 533-536, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076924
13.
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.
N Engl J Med
; 369(18): 1681-90, 2013 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24171516
14.
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 124(8): 1259-65, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25016003
15.
Diffuse Large B-Cell Lymphoma Version 1.2016.
J Natl Compr Canc Netw
; 14(2): 196-231, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26850490
16.
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.
J Natl Compr Canc Netw
; 14(9): 1067-79, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587620
17.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Nature
; 463(7277): 88-92, 2010 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20054396
18.
A War on Two Fronts: Cancer Care in the Time of COVID-19.
Ann Intern Med
; 172(11): 756-758, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219410
19.
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Br J Haematol
; 171(4): 530-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343802
20.
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Blood
; 121(18): 3547-53, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23386127